DDEL-10. A NANOPARTICLE PLATFORM FOR INTRATHECAL DELIVERY OF THE HISTONE DEACETYLASE INHIBITOR (HDACi) PANOBINOSTAT IN METASTATIC OR RECURRENT MEDULLOBLASTOMA

INTRODUCTION: Panobinostat is a histone deacetylase inhibitor (HDACi) that is a clinical candidate for treatment of pediatric medulloblastoma and diffuse intrinsic pontine glioma. Panobinostat is poorly water-soluble and experiences a number of barriers to effective delivery. Here, we developed a no...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhuri, Sauradip, Mohammad, Afroz S, Zhang, Wenqui, Baker, Cassandra, Broughton, Colton W, Fowler, Martha J, Stabenfeldt, Sarah E, Wechsler-Reya, Robert J, Sandberg, David I, Elmquist, William F, Sirianni, Rachael W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Drug Delivery/Pharmacokinetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715872/
http://dx.doi.org/10.1093/neuonc/noaa222.045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715872/
http://dx.doi.org/10.1093/neuonc/noaa222.045

Ejemplares similares